Abstract
Intrathecal drug delivery device is an FDA-approved therapy for chronic pain management. The therapy is generally safe, but few serious complications have been reported. The complications related to implantation, device mechanical failure, and during reservoir refill are well described but issues related to refill when drug concentration has changed is less well described. We described a case of potential drug overdose during reservoir refill despite following all safety protocol.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
